MSH-6: extending the reliability of immunohistochemistry as a screening tool in Muir–Torre syndrome
- 1 February 2008
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 21 (2) , 159-164
- https://doi.org/10.1038/modpathol.3800997
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- MSH6 mutation in Muir?Torre syndrome: could this be a rare finding?British Journal of Dermatology, 2006
- Very low prevalence of germline MSH6 mutations in hereditary non-polyposis colorectal cancer suspected patients with colorectal cancer without microsatellite instabilityBritish Journal of Cancer, 2006
- Spectrum and frequencies of mutations inMSH2 andMLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancerInternational Journal of Cancer, 2005
- Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)New England Journal of Medicine, 2005
- Identification of Muir–Torre syndrome among patients with sebaceous tumors and keratoacanthomasCancer, 2005
- Hereditary nonpolyposis colorectal cancer and related conditionsAmerican Journal of Medical Genetics Part A, 2003
- ‘‘Second Hit’’ in Sebaceous Tumors from Muir–Torre Patients with Germline Mutations in MSH2: Allele Loss is Not the Preferred Mode of InactivationJournal of Investigative Dermatology, 2001
- Widespread microsatellite instability in sebaceous tumours of patients with the Muir-Torre syndromeBritish Journal of Dermatology, 1997
- Hereditary cancer: Two hits revisitedZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- The Muir-Torre syndrome: A 25-year retrospectJournal of the American Academy of Dermatology, 1995